Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Gasmi

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neuronsArmin Blesch, James Conner, Alexander Pfeifer, et al.
Brain Research|October 30, 2007
Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSAngelo C Lepore, Christine Haenggeli, Mehdi Gasmi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's diseaseMehdi Gasmi, Christopher D Herzog, Eugene P Brandon, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 9, 2021
Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular EdemaClaire M Gelfman, Ruslan Grishanin, Kristina Oresic Bender, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2007
Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeysChristopher D Herzog, Biplob Dass, James E Holden, et al.
Experimental Neurology|November 18, 2008
Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene deliveryAlan H Nagahara, Tim Bernot, Rod Moseanko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2018
Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular DegenerationRuslan Grishanin, Brian Vuillemenot, Pallavi Sharma, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 11, 2009
Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental strokeWei Zhu, Yongfeng Fan, Qi Hao, et al.
Journal of Structural Biology|December 21, 2019
Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2Antonette Bennett, Annahita Keravala, Victoria Makal, et al.
Neurobiology of Disease|January 20, 2009
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Ina Han, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neuronsArmin Blesch, James Conner, Alexander Pfeifer, et al.
Brain Research|October 30, 2007
Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALSAngelo C Lepore, Christine Haenggeli, Mehdi Gasmi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's diseaseMehdi Gasmi, Christopher D Herzog, Eugene P Brandon, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|April 9, 2021
Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular EdemaClaire M Gelfman, Ruslan Grishanin, Kristina Oresic Bender, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2007
Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeysChristopher D Herzog, Biplob Dass, James E Holden, et al.
Experimental Neurology|November 18, 2008
Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene deliveryAlan H Nagahara, Tim Bernot, Rod Moseanko, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2018
Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular DegenerationRuslan Grishanin, Brian Vuillemenot, Pallavi Sharma, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 11, 2009
Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental strokeWei Zhu, Yongfeng Fan, Qi Hao, et al.
Journal of Structural Biology|December 21, 2019
Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2Antonette Bennett, Annahita Keravala, Victoria Makal, et al.
Neurobiology of Disease|January 20, 2009
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Ina Han, et al.
Pageof 3